NASDAQ : VYNE
VYNE Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 28.56 USD (At close: Jul 27, 2026) · Market cap 19.05M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
VYNE Therapeutics Inc. (VYNE) reported revenue of 454.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 454.00K | 570.00K | 501.00K | 424.00K | 477.00K | 931.00K |
| Revenue | 454.00K | 570.00K | 501.00K | 424.00K | 477.00K | 931.00K |
| Gross Profit | 454.00K | 570.00K | 501.00K | 424.00K | 477.00K | 931.00K |
| Selling, General & Admin | 10.89M | 11.08M | 13.19M | 13.38M | 16.39M | 20.30M |
| Research & Development | 13.93M | 19.24M | 30.95M | 16.31M | 18.39M | 19.54M |
| Operating Expenses | 24.82M | 30.32M | 44.14M | 29.68M | 34.77M | 39.84M |
| Operating Income | -24.37M | -29.75M | -43.64M | -29.26M | -34.30M | -38.91M |
| Interest Expense | -5.61M | |||||
| Interest & Investment Income | 1.35M | 1.72M | 3.83M | 1.39M | 363.00K | |
| Other Non Operating Income (Expenses) | -135.00K | |||||
| EBT Excluding Unusual Items | -23.01M | -28.03M | -39.80M | -27.87M | -33.93M | -44.66M |
| Other Unusual Items | 1.30M | 1.30M | ||||
| Pretax Income | -21.71M | -26.73M | -39.80M | -27.87M | -33.93M | -44.66M |
| Income Tax Expense | 4.00K | 4.00K | 4.00K | 13.00K | -448.00K | |
| Earnings From Continuing Operations | -21.72M | -26.74M | -39.81M | -27.87M | -33.95M | -44.21M |
| Earnings From Discontinued Operations | 261.00K | 253.00K | -27.00K | -580.00K | 10.73M | -29.12M |
| Net Income | -21.46M | -26.48M | -39.83M | -28.45M | -23.21M | -73.33M |
| Preferred Dividends & Other Adjustments | 149.00K | |||||
| Net Income to Common | -21.46M | -26.48M | -39.83M | -28.60M | -23.21M | -73.33M |
| Shares Outstanding (Basic) | 855.84K | 855.36K | 851.78K | 205.46K | 63.72K | 57.18K |
| Shares Outstanding (Diluted) | 855.84K | 855.36K | 851.78K | 205.46K | 63.72K | 57.18K |
| EPS (Basic) | -25.07 | -30.96 | -46.77 | -139.20 | -364.25 | -1,282.42 |
| EPS (Diluted) | -25.07 | -30.96 | -46.77 | -139.20 | -364.25 | -1,282.42 |
| Free Cash Flow | -25.74M | -33.12M | -34.09M | -25.34M | -29.20M | -56.37M |
| Free Cash Flow Per Share | -30.08 | -38.73 | -40.02 | -123.34 | -458.25 | -985.78 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -5,367.40% | -5,219.12% | -8,709.98% | -6,900.47% | -7,189.73% | -4,179.48% |
| Profit Margin | -4,726.21% | -4,646.14% | -7,950.90% | -6,745.52% | -4,865.83% | -7,876.37% |
| Free Cash Flow Margin | -5,670.48% | -5,811.23% | -6,804.19% | -5,976.65% | -6,121.59% | -6,054.46% |
| EBITDA | -24.34M | -29.73M | -43.63M | -29.19M | -34.22M | -38.80M |
| D&A For EBITDA | 23.00K | 23.00K | 4.00K | 72.00K | 72.00K | 109.00K |
| EBIT | -24.37M | -29.75M | -43.64M | -29.26M | -34.30M | -38.91M |
| Revenue as Reported | 454.00K | 570.00K | 501.00K | 424.00K | 477.00K | 931.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 24.63M | 24.03M | 19.93M | 30.62M | 30.91M | 42.25M |
| Short-Term Investments | 297.00K | 4.98M | 41.59M | 62.63M | ||
| Cash & Short-Term Investments | 24.93M | 29.01M | 61.52M | 93.25M | 30.91M | 42.25M |
| Accounts Receivable | 7.58M | |||||
| Other Receivables | 5.00M | |||||
| Receivables | 5.00M | 7.58M | ||||
| Prepaid Expenses | 861.00K | 1.00M | 2.92M | 2.66M | 2.30M | 4.57M |
| Restricted Cash | 54.00K | 67.00K | 605.00K | |||
| Other Current Assets | 8.18M | |||||
| Total Current Assets | 25.79M | 30.01M | 64.44M | 95.96M | 38.27M | 63.19M |
| Property, Plant & Equipment | 84.00K | 90.00K | 206.00K | 207.00K | 354.00K | |
| Other Long-Term Assets | 60.00K | 2.26M | 1.51M | 2.48M | 3.51M | |
| Total Assets | 25.87M | 30.16M | 66.91M | 97.69M | 40.76M | 67.05M |
| Accounts Payable | 261.00K | 1.04M | 2.71M | 1.66M | 2.39M | 6.51M |
| Accrued Expenses | 975.00K | 1.35M | 8.59M | 3.51M | 4.26M | 6.06M |
| Current Portion of Leases | 99.00K | 115.00K | 349.00K | |||
| Other Current Liabilities | 3.42M | 2.25M | 2.69M | 5.49M | ||
| Total Current Liabilities | 1.24M | 2.40M | 14.82M | 7.54M | 9.35M | 18.41M |
| Long-Term Leases | 99.00K | |||||
| Other Long-Term Liabilities | 1.31M | |||||
| Total Liabilities | 1.24M | 2.40M | 14.82M | 8.95M | 9.35M | 18.41M |
| Common Stock | 3.00K | 3.00K | 1.00K | 1.00K | 5.00K | |
| Additional Paid-In Capital | 785.87M | 785.41M | 783.24M | 780.04M | 693.94M | 688.16M |
| Retained Earnings | -761.24M | -757.65M | -731.17M | -691.34M | -662.74M | -639.52M |
| Comprehensive Income & Other | 2.00K | 20.00K | 26.00K | |||
| Total Common Equity | 24.64M | 27.77M | 52.09M | 88.73M | 31.20M | 48.64M |
| Shareholders' Equity | 24.64M | 27.77M | 52.09M | 88.73M | 31.41M | 48.64M |
| Total Liabilities & Equity | 25.87M | 30.16M | 66.91M | 97.69M | 40.76M | 67.05M |
| Total Debt | 99.00K | 214.00K | 349.00K | |||
| Net Cash (Debt) | 24.93M | 29.01M | 61.42M | 93.04M | 30.91M | 41.90M |
| Net Cash Per Share | 29.13 | 33.91 | 72.10 | 452.83 | 485.06 | 732.79 |
| Filing Date Shares Outstanding | 667.06K | 666.46K | 304.20K | 281.98K | 65.28K | 62.41K |
| Total Common Shares Outstanding | 667.06K | 666.46K | 296.60K | 281.98K | 64.59K | 59.53K |
| Working Capital | 24.55M | 27.61M | 49.62M | 88.42M | 28.93M | 44.78M |
| Book Value Per Share | 36.93 | 41.66 | 175.61 | 314.69 | 483.05 | 816.99 |
| Tangible Book Value | 24.64M | 27.77M | 52.09M | 88.73M | 31.20M | 48.64M |
| Tangible Book Value Per Share | 36.93 | 41.66 | 175.61 | 314.69 | 483.05 | 816.99 |
| Machinery | 117.00K | 117.00K | 117.00K | 846.00K | ||
| Leasehold Improvements | 59.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.46M | -26.48M | -39.83M | -28.45M | -23.21M | -73.33M |
| Depreciation & Amortization | 23.00K | 23.00K | 4.00K | 72.00K | 109.00K | |
| Loss (Gain) From Sale of Assets | 282.00K | 93.00K | ||||
| Loss (Gain) From Sale of Investments | -472.00K | -778.00K | -2.44M | -255.00K | ||
| Stock-Based Compensation | 2.02M | 2.31M | 3.30M | 3.31M | 4.30M | 8.08M |
| Other Operating Activities | -1.00K | 1.00K | 3.90M | |||
| Change in Accounts Receivable | 5.18M | 4.21M | -899.00K | 405.00K | 11.21M | 7.71M |
| Change in Inventory | 97.00K | 113.00K | ||||
| Change in Accounts Payable | -10.98M | -12.31M | 6.01M | -559.00K | -8.68M | -2.67M |
| Change in Other Net Operating Assets | -62.00K | -99.00K | -114.00K | 214.00K | -349.00K | -371.00K |
| Operating Cash Flow | -25.74M | -33.12M | -33.97M | -25.34M | -29.20M | -56.37M |
| Capital Expenditures | -117.00K | |||||
| Investment in Securities | 22.24M | 37.37M | 23.48M | -62.35M | 1.03M | |
| Other Investing Activities | 5.00M | 15.67M | ||||
| Investing Cash Flow | 22.24M | 37.37M | 23.36M | -57.35M | 15.67M | 1.03M |
| Long-Term Debt Repaid | -36.43M | |||||
| Net Debt Issued (Repaid) | -36.43M | |||||
| Issuance of Common Stock | 82.82M | 1.47M | 76.50M | |||
| Repurchase of Common Stock | -71.00K | -143.00K | -141.00K | -67.00K | -28.00K | -294.00K |
| Financing Cash Flow | -71.00K | -143.00K | -141.00K | 82.39M | 1.65M | 39.78M |
| Net Cash Flow | -3.58M | 4.10M | -10.75M | -301.00K | -11.88M | -15.56M |
| Free Cash Flow | -25.74M | -33.12M | -34.09M | -25.34M | -29.20M | -56.37M |
| Free Cash Flow Margin | -5,670.48% | -5,811.23% | -6,804.19% | -5,976.65% | -6,121.59% | -6,054.46% |
| Free Cash Flow Per Share | -30.08 | -38.73 | -40.02 | -123.34 | -458.25 | -985.78 |
| Levered Free Cash Flow | -20.40M | -26.67M | -17.00M | -12.25M | -11.86M | -15.97M |
| Unlevered Free Cash Flow | -20.40M | -26.67M | -17.00M | -12.25M | -11.86M | -12.47M |
| Cash Interest Paid | 2.38M | |||||
| Change in Working Capital | -5.86M | -8.19M | 5.00M | 60.00K | 2.28M | 4.78M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 19.05M | 19.31M | 49.42M | 32.52M | 8.71M | 54.59M |
| Enterprise Value | -5.88M | -13.39M | -20.64M | 17.07M | -26.80M | 3.33M |
| Last Close Price | 28.56 | 16.36 | 94.50 | 65.73 | 76.17 | 517.93 |
| PS Ratio | 41.96 | 33.88 | 98.64 | 76.70 | 18.25 | 58.63 |
| PB Ratio | 0.77 | 0.69 | 0.95 | 0.37 | 0.28 | 1.12 |
| P/TBV Ratio | 0.77 | 0.69 | 0.95 | 0.37 | 0.28 | 1.12 |
| EV/Sales Ratio | 40.27 | 3.58 | ||||
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | |||
| Net Debt / Equity Ratio | -1.01 | -1.04 | -1.18 | -1.05 | -0.98 | -0.86 |
| Net Debt / EBITDA Ratio | 1.02 | 0.98 | 1.41 | 3.19 | 0.90 | 1.08 |
| Net Debt / FCF Ratio | 0.97 | 0.88 | 1.80 | 3.67 | 1.06 | 0.74 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Quick Ratio | 20.17 | 12.11 | 4.15 | 12.37 | 3.84 | 2.71 |
| Current Ratio | 20.86 | 12.53 | 4.35 | 12.73 | 4.10 | 3.43 |
| Return on Equity (ROE) | -63.16% | -66.97% | -56.54% | -46.40% | -84.81% | -102.66% |
| Return on Assets (ROA) | -37.01% | -38.31% | -33.14% | -26.42% | -39.77% | -30.25% |
| Return on Capital Employed (ROCE) | -98.90% | -107.10% | -83.80% | -32.50% | -109.20% | -80.00% |
| Earnings Yield | -112.63% | -137.15% | -80.61% | -87.49% | -266.62% | -134.33% |
| FCF Yield | -135.13% | -171.54% | -68.98% | -77.92% | -335.43% | -103.26% |
| Buyback Yield / Dilution | -0.42% | -0.42% | -314.57% | -222.44% | -11.44% | -58.75% |